Respiratorius

2.25 SEK

-13.46%

Less than 1K followers

RESP

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

-13.46 %
+57.34 %
+70.45 %
+38.89 %
+15.68 %
-53.51 %
-91.27 %
-97.56 %
-84.28 %

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.

Read more
Market cap
17.78M SEK
Turnover
141.5K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.5
2026

Interim report Q1'26

9.6
2026

General meeting '26

11.8
2026

Interim report Q2'26

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools